Leverage Shares 2x 2JPM JPMorgan ETP Investment Objective PRODUCT INFORMATION The Leverage Shares 2x JPMorgan ETP Securities seeks to track the NYSE Leveraged 2x Product Name Leverage Shares 2x JPMorgan ETP JPM Index, which is designed to provide 2x the daily return of JPMorgan Chase & Co. stock, Underlying Security JPMorgan Chase & Co. adjusted to reflect the fees and costs of maintaining a leveraged position in the stock. It invests directly in the underlying JPMorgan Chase & Co. stock and uses margin (borrowing) Leverage Factor 2 to purchase additional shares of JPMorgan Chase & Co. stock. Replication Physical (Underlying Assets Owned) Base CurrencyUSD For example, if JPMorgan Chase & Co. rises by 1% over a day, then the ETP will rise by 2%, excluding fees. However, if JPMorgan Chase & Co. falls by 1% over a day, then the ETP willISIN IE00BF03XW61 fall by 2%, excluding fees. Structure / Legal Form ETP / Debt Security Countries Available United Kingdom, Italy, Germany, France, Key Features Spain, Netherlands, Ireland, Poland andBelgium •Opportunity to magnify returns in one simple trade. Issuer Leverage Shares PLC •Liquid. Trades like an equity on exchange, with multiple market makers (MMs). Trustee Apex Corporate Trustees (UK) Limited •You cannot lose more than the amount invested, and an intraday rebalance mechanism Margin Provider Interactive Brokers Ireland Limitedis designed to cushion the largest intra-day falls. Fed Funds Effective (Overnight Rate) Margin Rate +1.5% •Simple to trade, no need for futures, no need to use margin accounts. Annual Management Fee 0.75% •Transparent structure with full ownership of the underlying assets, so credit risk SIPP/ISA EligibleYeseffectively negated. Sec 871(m) Not Applicable (see FAQs) • Is independent and managed by industry experts. INDEX INFORMATION IndexNYSE Leveraged 2x JPM Index Key Risks Index Provider NYSE® Group, Inc •Investing in Short and Leveraged ETPs is only suitable for sophisticated traders who Index Currency USDunderstand leverage, daily rebalancing and compounded daily returns. Index Ticker NY2LJPM •Investors can lose the full value of their initial investment (but not more).•Losses are magnified due to the nature of leveraged returns. Therefore, Short andLeveraged ETPs are only suitable for investors willing to take a high level of risk.•Daily compounding may result in returns which an investor may not expect if theinvestor has not fully understood how a Leverage Shares ETP works.•Due to daily rebalancing and compounding, ETP returns measured over periods longerthan one day may differ from the returns of the underlying stock multiplied by theleverage factor.•Only use these ETPs if you can monitor your positions daily or during the day. •Please see the ‘Risks Factors’ section of the Prospectus for a more detailed discussionInvestors should refer to the Prospectus (www.leverageshares.com) for a more completeof the potential risks associated with an investment in this product. description of the product, service providers and relevant regulatory factors. BASE TRADING EXCHANGE LISTING COUNTRY EXCHANGEISIN SEDOLBBG RIC CURRENCY CURRENCY CODE DATE London Stock UKUSD USD JPM2 IE00BF03XW61 BF03XW6 JPM2 LN JPM2.L 12/12/2017 Exchange London Stock UK USD GBx 2JPM IE00BF03XW61 BYX8558 2JPM LN 2JPM.L 12/12/2017 Exchange London Stock UKUSD EUR JP2E IE00BF03XW61 BJKX807 JP2E LN JP2E.L 12/12/2017 Exchange Euronext Netherlands USD EUR 2JPM IE00BF03XW61 2JPM NA 2JPM.AS12/01/2021 Amsterdam 2JPM Leverage Shares 2x JPMorgan ETPContact Information Contact us at via email at info@leverageshares.com or on Twitter at @LeverageShares. More information on Leverage Shares can we found online at www.leverageshares.com. Disclaimer Leverage Shares ETPs are only intended for sophisticated traders who understand the associated risks and are able to monitor their positions on an intraday basis. Please consult an investment adviser to determine whether or not the products are suitable for you. Traders should also review the Relevant Prospectus and the Leverage Shares educational materials carefully before considering the ETPs. No investment advice Leverage Shares PLC is required by the FCA to clarify that it is not acting for you in any way in relation to the investment or investment activity to which this financial promotion relates. In particular, LEVERAGE SHARES PLC will not provide any investment services to you and or advise you on the merits of, or make any recommendation to you in relation to, the terms of any transaction. No representative of LEVERAGE SHARES PLC is authorised to behave in any way which would lead you to believe otherwise. LEVERAGE SHARES PLC is not, therefore, responsible for providing you with the protections afforded to its clients and you should seek your own independent legal, investment and tax or other advice as you see fit. No offer for sale The information contained in this financial promotion is neither an offer for sale nor a solicitation of an offer to buy securities. This financial promotion should not be used as the basis for any investment decision. Risk Warnings The value of an investment in ETPs may go down as well as up and past performance is not a reliable indicator of future performance. An investment in ETPs is dependent on the performance of the underlying index, less costs, but it is not expected to match that performance precisely. ETPs offering daily leveraged or daily short exposures (“Leveraged ETPs”) are products which feature specific risks that prospective investors should understand before investing in them. Securities issued by the Issuer are products involving a significant degree of risk and may not be suitable for all types of investor. Any decision to invest should be based on the information contained in the Relevant Prospectus of the Issuer (or any supplements thereto) which includes, inter alia, information on certain risks associated with an investment. The price of any securities may go up or down and an investor may not get back the amount invested. Securities are priced in US Dollars/Euros/Pounds and the value of the investment in other currencies will be affected by exchange rate movements. Short and leveraged exchange-traded products are only intended for investors who understand the risks involved in investing in a product with short and/or leveraged exposure and who intend to invest on a short-term basis. Any investment in short and/or leveraged products should be monitored on a daily basis to ensure consistency with your investment strategy. You should understand that investments in short and/or leveraged exchange-traded products held for a period of longer than one day may not provide returns equivalent to the return from the relevant unleveraged investment multiplied by the relevant leverage factor. Potential losses in short and/or leveraged exchange-traded products may be magnified in comparison to investments that do not incorporate these strategies. Please refer to the section entitled “Risk Factors” in the relevant prospectus for further details of these and other risks associated with an investment in short and/or leveraged exchange-traded products. You should consult an independent investment adviser prior to making an investment in short and/or leveraged exchange-traded products in order to determine its suitability to your circumstances. Prospectus A base prospectus has been approved by the Central Bank of Ireland as competent authority under Regulation (EU) 2017/1129 with respect to the offer and listing of ETPs in Ireland and certain other EU jurisdictions listed below (the “EU Prospectus”). A base prospectus has been approved by the Financial Conduct Authority as competent authority under the United Kingdom’s version of Regulation (EU) No 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018 with respect to the offer and listing of ETPs in the United Kingdom. The Central Bank of Ireland has delivered to the regulators listed below certificates of approval attesting that the EU Prospectus has been drawn up in accordance with Article 25 of Regulation (EU) 2017/1129. The EU Prospectus (and any supplements thereto) of the Issuer has been passported from Ireland into Italy (Commissione Nazionale per la Societá e la Borsa), Germany (Bundesanstalt für Finanzdienstleistungsaufsicht ) , France (Autorité des Marchés Financiers), Spain (Comisión Nacional del Mercado de Valores), the Netherlands (the Autoriteit Financiële Markten), Poland (Komisja Nadzoru Finansowego) and Belgium (Belgian Financial Services and Markets Authority). Investors should read the Relevant Prospectus of the Issuer before investing and should refer to the section of the Relevant Prospectus entitled ‘Risk Factors’ for further details of risks associated with an investment in this product. 2ndFloor,Block5, Irish Life Centre,Abbey Street Lower, Dublin 1,D01 P767 email info@leverageshares.com website www.leverageshares.c